Evidence map›Paper›PMID 25510507›Full record

ArticleBMC cancer2014

Care provided and care setting transitions in the last three months of life of cancer patients: a nationwide monitoring study in four European countries.

Winne Ko, Luc Deliens, Guido Miccinesi, Francesco Giusti, Sarah Moreels, Gé A Donker, Bregje Onwuteaka-Philipsen, Oscar Zurriaga, Aurora López-Maside, Lieve Van den Block and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cancer and end of life: the management provided during the year and the month preceding death in 2015 and causes of death in France.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Improving palliative care provision in primary care: a pre- and post-survey evaluation among PaTz groups.The British journal of general practice : the journal of the Royal College of General Practitioners · 2018
    Article
  19. Article
  20. Impact of intensity and timing of integrated home palliative cancer care on end-of-life hospitalization in Northern Italy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 4 countries.

Winne KoEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels and Ghent University, Ghent, Belgium. winne.ko@vub.ac.be.
Luc Deliens
Guido Miccinesi
Francesco Giusti
Sarah Moreels
Gé A Donker
Bregje Onwuteaka-Philipsen
Oscar Zurriaga
Aurora López-Maside
Lieve Van den Block
EURO IMPACT
Ghent University · BEPiedmont Reference Center for Epidemiology and Cancer Prevention · ITCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESEMGO Institute for Health and Care Research · NLGeneralitat Valenciana · ESInstitut Scientifique de Santé Publique · BENetherlands Institute for Health Services Research · NLVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis is an international study across four European countries (Belgium[BE], the Netherlands[NL], Italy[IT] and Spain[ES]) between 2009 and 2011, describing and comparing care and care setting transitions provided in the last three months of life of cancer patients, using representative GP networks.

methodsGeneral practitioners (GPs) of representative networks in each country reported weekly all non-sudden cancer deaths (+18y) within their practice. GPs reported medical end-of-life care, communication and circumstances of dying on a standardised questionnaire. Multivariate logistic regressions (BE as a reference category) were conducted to compare countries.

resultsOf 2,037 identified patients from four countries, four out of five lived at home or with family in their last year of life. Over 50% of patients had at least one transition in care settings in the last three months of life; one third of patients in BE, IT and ES had a last week hospital admission and died there. In the last week of life, a treatment goal was adopted for 80-95% of those having palliation/comfort as their treatment goal. Cross-country differences in end-of-life care provision included GPs in NL being more involved in palliative care (67%) than in other countries (35%-49%) (OR 1.9) and end-of-life topics less often discussed in IT or ES. Preference for place of death was less often expressed in IT and ES (32-34%) than in BE and NL (49-74%). Of all patients, 88-98% were estimated to have distress from at least one physical symptom in the final week of life.

conclusionAlthough palliative care was the main treatment goal for most cancer patients at the end of life in all four countries, frequent late hospital admissions and the symptom burden experienced in the last week of life indicates that further integration of palliative care into oncology care is required in many countries.

Indexed as

Palliative CareTerminal CareAdultAgedAged, 80 and overBelgiumFemaleHumansItalyMaleMiddle AgedMultivariate AnalysisNeoplasmsNetherlandsRetrospective StudiesSpain

Identifiers

PMID25510507
PMCPMC4301937
OpenAlexW1849338374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.